Purpose: Renal tumor enucleation allows for maximal parenchymal preservation. Identifying pseudocapsule integrity is critically important in nephron sparing surgery by enucleation. Tumor invasion into and through the capsule may have clinical implications, although it is not routinely commented on in standard pathological reporting. We describe a system to standardize the varying degrees of pseudocapsule invasion and identify predictors of invasion. Materials and Methods: We performed a multicenter retrospective review between 2002 and 2014 at Indiana University Hospital and Loyola University Medical Center. A total of 327 tumors were evaluated following removal via radical nephrectomy, standard margin partial nephrectomy or enucleation partial nephrectomy. Pathologists scored tumors using our i-Cap (invasion of pseudocapsule) scoring system. Multivariate analysis was done to determine predictors of higher score tumors. Results: Tumor characteristics were similar among surgical resection groups. Enucleated tumors tended to have thinner pseudocapsule rims but not higher i-Cap scores. Rates of complete capsular invasion, scored as i-Cap 3, were similar among the surgical techniques, comprising 22% of the overall cohort. Papillary histology along with increasing tumor grade was predictive of an i-Cap 3 score. Conclusions: A capsule invasion scoring system is useful to classify renal cell carcinoma pseudocapsule integrity. i-Cap scores appear to be independent of surgical technique. Complete capsular invasion is most common in papillary and high grade tumors. Further work is warranted regarding the relevance of capsular invasion depth as it relates to the oncologic outcome for local recurrence and disease specific survival.
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Key Words: kidney neoplasms; carcinoma, renal cell; nephrectomy; neoplasm invasiveness; classification PARTIAL nephrectomy remains the preferred surgical therapy for renal masses less than 7 cm when feasible, secondary to the well described benefits of nephron preservation and equivalent oncologic outcomes compared to radical nephrectomy. 1, 2 Tumor enucleation is a nephron The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number. Recently, a tumor enucleation approach has become more prevalent in the surgical management of sporadic renal masses with promising initial results. 4, 5 Renal tumor enucleation takes advantage of the renal tumor pseudocapsule, consisting of a fibrous band of compressed renal parenchyma that isolates the tumor from the surrounding healthy renal parenchyma and provides a natural dissection plane during surgery ( fig. 1) . 6 When compared to standard margin partial nephrectomy for RCC, tumor enucleation has demonstrated comparable oncologic outcomes in some series. 7 Opponents of this technique caution that the integrity of the tumor pseudocapsule may predict the presence of a positive surgical margin. Although several publications have suggested that a positive margin does not predict tumor recurrence after partial nephrectomy, pathological invasion of the tumor pseudocapsule may have an important role in predicting cancer recurrence and overall worse outcomes.
8e12 Surgeons recently purposely enucleated renal tumors at the base of the tumor-parenchyma interface, leading to a new standardization of surgical technique reporting. 5 Currently, to our knowledge there are no protocols for pathologists to characterize the integrity of the renal tumor pseudocapsule. Further, the status of the pseudocapsule (presence or absence and invasion into it) is not routinely reported to the treating urologist. In collaboration with the pathology and urology departments at our respective institutions we sought to create i-Cap, a new, simple and easily reproducible scoring system to assess the integrity of the renal tumor pseudocapsule. We used this system to evaluate pathological specimens treated during a 12-year period. In addition, we investigated the clinical parameters that may ultimately serve as pseudocapsule integrity predictors and that may influence preoperative evaluation in an attempt to improve future patient outcomes.
MATERIALS AND METHODS

Patient Selection
We performed a multicenter retrospective cohort study at Indiana University Hospital and Loyola University Medical Center from October 2002 to December 2014. Patients who underwent renal surgery with clear, papillary or chromophobe histological subtypes were included in study. Patients with clinical T1 staging preoperatively were included but higher staged, more aggressive tumors were excluded from analysis. Patients with benign renal tumors such as oncocytoma and angiomyolipoma were also excluded. Overall, 327 patients who underwent radical nephrectomy, standard margin partial nephrectomy or enucleation partial nephrectomy were included in study.
Pathological Assessment
Trained genitourinary pathologists at each institution (MMP and MTI) reviewed each pathological specimen. Tumors were staged according to the pTNM guidelines in the AJCC (American Joint Committee on Cancer) Staging Manual, 7th edition, and graded according to the criteria set out by the Fuhrman grading system.
13e15 Tumor characteristics such as histological subtype, mean pseudocapsule thickness, pseudocapsule completeness, presence and extent of pseudocapsule invasion, and surgical margin status were reviewed. Sections from the entire tumor-parenchyma interface were examined in all cases.
Each tumor received an i-Cap score of 1 to 3 in accordance with the newly introduced i-Cap scoring system for pseudocapsule invasion ( fig. 2 ). An i-Cap score of 1 was assigned to tumors with a completely intact pseudocapsule without cancerous invasion. An i-Cap score of 2 was assigned to tumors that had focal absences in the pseudocapsule without invasion or cancerous tissue invasion partially into and yet not completely through the pseudocapsule. An i-Cap score of 3 was assigned to tumors that had completely lost pseudocapsule integrity with carcinoma extending into surrounding healthy parenchyma ( fig. 2 ).
Statistical Analysis
Clinical and demographic variables were compared across sites and by surgical technique. The chi-square and Fisher exact tests were used for categorical comparisons when appropriate. The independent t-test and 1-way ANOVAs were used for continuous comparisons. Multivariable binary logistic regression was performed to assess predictors of i-Cap 3 vs 1 and 2 tumors by a stepwise selection procedure and AIC criterion. Statistical significance was considered at a ¼ 0.05. All analyses were performed with SASÒ, version 9.4. Invasion into the pseudocapsule (i-Cap) scores were assigned to all tumors included in analysis. i-Cap 1, 2 and 3 were assigned to 79 (24.2%), 176 (53.8%) and 72 tumors (22%), respectively. Except for i-Cap 3 tumors the scores were distributed evenly among the surgical technique (p ¼ 0.09). More i-Cap 3 tumors were treated with tumor enucleation than with radical nephrectomy and standard margin partial nephrectomy (16% vs 25% and 21%, respectively).
Mean pseudocapsule thickness was 0.77 AE 0.69 cm. Pseudocapsule thickness depended on surgical technique as thinner pseudocapsules were observed in the enucleation group. Mean pseudocapsule thickness in the radical nephrectomy, standard margin partial nephrectomy and enucleation partial nephrectomy groups was 0.77, 0.83 and 0.54 cm, respectively (p ¼ 0.047). Positive surgical margins were present overall in 11 cases (3.4%). Ten of the 11 patients who had a positive surgical margin underwent standard margin partial nephrectomy while the remaining patient with a positive margin underwent radical nephrectomy. None of the patients treated with tumor enucleation had a positive margin on pathological analysis.
Multivariate analysis was completed to investigate factors associated with renal tumors that were more likely to demonstrate a higher i-Cap score, indicating complete invasion ( The literature has demonstrated that the amount of parenchyma spared during these resections can directly correlate with improved long-term functional outcomes. 16, 17 In light of these observations, parenchymal function preservation has been pursued by focusing on decreasing warm ischemia time or maximizing spared renal parenchyma tissue during extraction. Enucleation partial nephrectomy provides the opportunity to achieve both ends while producing oncologic outcomes comparable to those achieved by standard margin partial nephrectomy. 7,18e21 Enucleation leverages the integrity of the In our study we were able to characterize and classify the tumor pseudocapsule in T1 RCC by evaluating degrees of integrity and invasion in a previously operated set of patients. Additionally, we were able to determine that tumor grade and tumor histology may have a significant role in predicting a higher invasion (i-Cap) score. We hope that this simple scoring system may be adopted, studied and implemented by the evaluating pathologist when reporting to the managing urologist.
Initially developed as an intervention for patients with hereditary renal syndrome, tumor enucleation uses the pseudocapsule-parenchyma interface via blunt dissection along natural cleavage planes while sparing healthy surrounding parenchyma. 3, 22 The close border between tumor and healthy renal tissue manipulated during enucleation creates concern regarding margin status and the potential for iatrogenic rupturing of the pseudocapsule during extraction, which may impact pathological processing. 23 Despite this, multiple studies by Minervini et al have demonstrated that even a relatively thin pseudocapsule successfully guards against iatrogenic increases in positive margin rates. 11, 12 Our data revealed a positive surgical margin rate of 3.4% in all cases with no positive surgical margin in the enucleation group. Despite the absence of an increased margin rate, we observed the thinnest pseudocapsule in the enucleation group compared with the other groups, suggesting that some degree of pseudocapsule may be altered when using this technique. If tumor pseudocapsule invasion was principally a function of pseudocapsule thickness, it may be assumed that the enucleation group would have had the highest i-Cap scores. The opposite was true when analyzing our data since the lowest i-Cap 3 rate was in the enucleation cohort. Whether this was a function of the technique or a byproduct of appropriate selection remains unknown. In any event, it at least suggests that surgical technique (standard margin vs enucleation partial nephrectomy) is not a critical predictor of capsule invasion and of itself should not dissuade surgeons from considering tumor enucleation as a viable option.
The tumor pseudocapsule has been well described as a fibrous band of compressed renal parenchymal tissue encompassing most RCC. The integrity of the pseudocapsule may vary greatly depending on the histological features of the tumor that it surrounds. 11, 13, 24 Previous literature has revealed that tumor subtype may be predictive of pseudocapsule characteristics.
11e13 Additionally, higher rates of penetrating pseudocapsule disease in RCC may be seen in patients with higher Fuhrman grade tumors and more advanced TNM stage. 6,8e10,24 In the current study i-Cap scores of 1, 2 and 3 were assigned to 79 (24%), 176 (54%) and 72 tumors (22%), respectively, in the entire cohort. Tumors scored as i-Cap 2 made up the largest percent of the cohort. i-Cap 3 scored tumors showed complete loss of pseudocapsule integrity with penetration of tumor directly into surrounding parenchyma. They carried the highest risk of loss of negative margin status. Although it is currently debated, early studies of the clinical implications of positive margins demonstrated a higher risk of tumor recurrence and should be avoided in all cases. 25, 26 Even when a positive margin never evolves into a clinically significant recurrence, the impact of rigorous surveillance may cause financial and emotional burdens on the patient.
27,28 The i-Cap scoring system can provide an essential tool not only to the pathologist but also to the treating urologist to aid in the creation of an appropriate postoperative care plan for the patient with renal cell cancer.
Considering the importance of positive margins status and concurrent loss of pseudocapsule integrity, we performed multivariate analysis in this study to investigate factors associated with i-Cap 3 tumors that may be preoperatively assessable by biopsy and imaging. In our analysis papillary type RCC carried the highest chance of i-Cap 3 scores compared to other histological subtypes (OR 3.04, 95% CI 1.52e6.09, p ¼ 0.002). An increasing risk of an i-Cap 3 score was also observed in higher Fuhrman grade tumors with grade 4 carrying the highest risk (OR 14.68, 95% CI 2.16e123.18, p ¼ 0.007). We believe that these data imply that papillary histology and highly aggressive nuclear features observed on biopsy require special attention to margin status during the perioperative period. This study may also suggest that, regardless of small tumor size, enucleation may not be clinically indicated for tumors with these histological features.
Creating a pseudocapsule scoring system that is easily implemented and interpreted is becoming increasingly important as interest in the consideration of enucleation partial nephrectomy of the sporadic solitary renal mass expands. Indeed, there is an effort to codify surgical approaches in which enucleation is variably or partially used in the surgical approach. In a recent study the SIB margin score was created to comment on the macroscopic remnant pseudocapsule surrounding the tumor. 5 The investigators attempted to validate the scoring system in a followup analysis. 29 The SIB scoring system is predicated on surgeon ability to accurately assess the presence or absence of residual parenchyma around various sections of the removed renal tumor. The i-Cap scoring system, which is determined by histopathological analysis, may function as an ideal complement to the SIB system, in that it may provide checks and balances to the surgeon assessment on the microscopic level. This could allow for improvement in the standardization of reporting and hopefully provide a valuable tool for tumor prognostication. Clearly, the ultimate usefulness and integration of the 2 scoring systems for RCC have yet to be fully defined.
The current study carries notable limitations. Pathological scoring was done in retrospective fashion after the initial pathological review was completed. Additionally, some i-Cap scores may have been upgraded secondary to iatrogenic disruption of the pseudocapsule during surgical removal and/or specimen processing. Interobserver variations and institutional biases may have existed among the pathologists who graded pseudocapsule integrity. Although the i-Cap scoring system is a quality tool to standardize the assessment of the renal tumor pseudocapsule, the clinical implication of this grading tool has yet to be defined and it requires longer followup.
These limitations notwithstanding, to our knowledge this report represents the first attempt to classify the integrity of the tumor pseudocapsule through the creation of an easy and simple reproducible scoring system for RCC.
CONCLUSIONS
In our study we propose a capsule invasion scoring system that may be useful to further classify the pseudocapsule integrity of small renal masses. Although tumor enucleation may attenuate the pseudocapsule, the integrity of the capsule seems to be independent of surgical technique. Complete tumor pseudocapsule invasion into the surrounding renal parenchyma appears most common in papillary histological subtype and high grade tumors. Further work is warranted regarding implementation of the i-Cap scoring system and investigation of the clinical implications of higher i-Cap scores. 
EDITORIAL COMMENTS
Mounting evidence indicates that preservation of the renal parenchyma is a primary factor in postpartial nephrectomy renal function (reference 16 in article). Furthermore, numerous publications suggest that a positive surgical margin in clear cell RCC does not correspond to residual tumor tissue and complete tumor removal is the most important factor (reference 27 in article). Consequently, renal tumor enucleation has recently become a more widely used approach (reference 23 in article). At NCI (National Cancer Institute) we recommend renal tumor enucleation in select patients at risk for multifocal, genetically defined types of RCC such as VHL mutated clear cell RCC, MET mutated type 1 papillary RCC and FLCN mutated RCC as seen in Birt-Hogg-Dub e syndrome. We do not perform enucleation in patients with TFE3 RCC, HLRCC (hereditary leiomyomatosis and RCC) associated tumors or succinate dehydrogenase altered RCC. We believe this to be a safe procedure for most but certainly not all genetically defined small renal tumors.
The authors present data to define rates of pseudocapsule invasion by tumor as well as standardize pathological reporting of this phenomenon. To determine which patients are at highest risk for local tumor recurrence it is imperative that pathological reporting is standardized. The i-Cap grading system must be externally validated but this report is an important first step toward that end.
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The twin goals of complete tumor resection and maintenance of postoperative renal function continue to drive refinements in partial nephrectomy technique. The importance of maximal renal parenchymal volume preservation alludes to the potential benefit of tumor enucleation (reference 16 in article), which depends on the presence of a pseudocapsule. Recently, the SIB scoring system, a novel method of assessing the pseudocapsule and reporting renal margin thickness, was published (reference 29 in article). In the current study Snarskis et al propose the i-Cap scoring system to classify pseudocapsule tumor involvement as a complement to the SIB system. The proposed i-Cap system is easily adoptable by pathologists, although interobserver variability will be present due to the subjective nature of the histological criteria selected. If validated, the system could provide a uniform nomenclature, which is needed for prospective comparative studies. Ultimately, head-tohead trials of enucleation vs traditional partial nephrectomy are needed to evaluate the efficacy of these 2 surgical strategies (reference 23 in article). 
REPLY BY AUTHORS
The comments appropriately caution that ubiquitous implementation of tumor enucleation may be premature based on currently available evidence. Although in general we agree with the comments, it should be noted that partial nephrectomy was developed, refined and used as the standard of care long before level 1 evidence emerged regarding its safety and efficacy for treating RCC. If the critical tenets of nephron sparing surgery are preserved, including tumor removal with negative margins, renal parenchymal preservation and patient safety, how important in actuality are the nuances of technical resection? In addition, many surgeons practice enucleation in some form in select cases. Caution aside, the main focus of our collaboration was in fact not to define which tumor should or should not be enucleated but rather to introduce an easily reproducible grading system to better describe the tumor-pseudocapsule interface. By enabling standardization of tumor pseudocapsule integrity we may better understand tumor behavior beyond what is traditionally reported by the interpreting pathologist. In addition, it may allow for surgeons to have confidence in regard to the interpretation of margin status, thus, dropping a barrier to the adoption of the technique.
With validation and longer term analysis we hope that we may be able to develop a preoperative risk model for tumor capsule invasion that may aid in the selection of management (active surveillance, or partial or radical nephrectomy) or technique (traditional vs enucleative partial nephrectomy) as well as contribute to the refinement of postoperative surveillance pathways.
